4//SEC Filing
Nijhawan Pardeep 4
Accession 0001171843-25-000868
CIK 0001540159other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:01 PM ET
Size
6.5 KB
Accession
0001171843-25-000868
Insider Transaction Report
Form 4
Nijhawan Pardeep
DirectorChief Executive Officer10% Owner
Transactions
- Award
Series B-1 Convertible Preferred Shares
2025-02-12+100→ 100 totalExercise: $1.92From: 2025-02-12→ Common Shares (520,833 underlying)
Footnotes (3)
- [F1]The Preferred Shares are perpetual and therefore have no expiration date.
- [F2]Each Preferred Share is convertible at any time, at the option of the holder, into a number of common shares determined by dividing the stated value of the Preferred Share ($10,000 per share), plus all other amounts due in respect of such Preferred Share (excluding distributions), by the conversion price at the time of conversion.
- [F3]On February 11, 2025, the Reporting Person purchased in a private placement, 100 shares of the Issuer's newly designated Series B-1 Convertible Preferred Shares (the "Preferred Shares"), stated value $10,000 per share for an aggregate purchase price of $1.0 million. The Preferred Shares are immediately convertible at $1.92 per share, to the extent that after giving effect to such conversion the Reporting Person and his affiliates would beneficially own, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, no more than 19.99% of the outstanding common shares of the Issuer.
Documents
Issuer
Edesa Biotech, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001777962
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:01 PM ET
- Size
- 6.5 KB